For example, Gáll et al. (2022) showed that the oral administration of CBD (60 mg/kg) prevented the proliferation of GFAP-positive cells in the hippocampus of the rat pentylenetetrazol-kindling model of epilepsy, in alignment with the effect of peritoneal high dosage of CBD that exerts the same decrease in astrocyte hyperplasia [93]. Here, GFAP is linked to epilepsy.